Dizajniranje i vrednovanje bioadhezijskog filma za transdermalnu isporuku propranolol hidroklorida by BAZIGHA K. ABDUL RASOOL et al.
Oral administration is one of the most convenient ways that are acceptable for pa-
tients, useful and suitable for drugs that are not subjected to intestinal and/or hepatic
first-pass metabolism (1). However, there are several shortcomings that should be over-
come to achieve efficient drug therapy: the intestinal and/or hepatic first-pass elimina-
tion, high variance in bioavailability, difficulty in long-term and rate-regulated absorp-
tion and impossibility of arbitrary drug input and its interruption (2). Transdermal route
is one of the potential alternative routes that may bypass undesirable characteristics of
oral administration. Propranolol, a b-blocker, has short biological half-life and is exten-
sively subjected to hepatic first-pass metabolism (3). Propranolol · HCl (Mr 135, water
solubility > 150 mg mL–1) can be a potential candidate for transdermal use. Recently, de-
velopment of transdermal drug delivery systems (TDDS) has been focused on the for-
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mulation part to achieve the desirable constant rate of drug penetration into the syste-
mic circulation. One way to design a TDDS is by employing polymers as matrices or
membranes controlling the release of drugs (4). On the other hand, the impermeability
of human skin is still a fundamental problem to be overcome for the therapeutic use of
TDDS (5). Although many physical approaches such as ultrasound, iontophoresis and
electroporation have been proposed to surmount the stratum corneum, the main barrier
for transdermal drug absorption (2), chemical approaches such as the utilization of en-
hancers might be the easiest way to patch preparations. Among many enhancers, ter-
penes have been extensively investigated for their clinical use as penetration enhancers
and are generally regarded as safe (GRAS) by FDA. It is suggested that terpenes increase
drug diffusivity in the skin by disrupting the intercellular lipid packing in the horny la-
yer (2). Considering the balance between efficiency and toxicity, several terpenes may be
promising enhancers for clinical use (6).
In the present study, a suitable film preparation of propranolol hydrochloride (PPL)
has been developed by employing chitosan polymer as a film former, and glycerine as a
plasticizer. Furthermore, in order to improve the penetration of PPL, enhancers includ-
ing terpenes (menthol and cineole), propylene glycol (PG), surfactants [sodium lauryl
sulphate (SLS), Tween® 80 and benzalkonium chloride (BZK)] and oleic acid (OA) were
employed. Physicochemical characterization of the films was done. In vitro release and
permeation profiles of PPL from film preparations were examined.
EXPERIMENTAL
Materials
Chitosan (medium molecular mass), PPL, HPLC-grade acetonitrile, oleic acid, po-
tassium dihydrogen orthophosphate, disodium hydrogen orthophosphate and phospha-
te buffer saline (PBS) tablets (pH 7.4) were all purchased from Sigma-Aldrich (UK). Di-
ethyl ether, sodium hydroxide, sodium lauryl sulphate, glycerol and potassium chloride
were obtained from BDH Chemicals Ltd. (UK). Silica gel was bought from Merck (Ger-
many). Cineole, menthol and benzalkonium chloride were from Fluka AG (UK). HPLC
grade glacial acetic acid was obtained from Fisons Scientific Equipment (UK). Double
distilled, de-ionised water was used throughout.
Preparation of PPL-chitosan film formulation
Chitosan film was prepared by dissolving 1 g of chitosan in 100 mL of acetic acid
(1 %, m/V) at room temperature. Glycerine was incorporated at a concentration of 10 %
(m/m) of the total dry mass of the polymer, as plasticizer. The resultant mixture was left
under stirring for 1 h until a viscous chitosan gel was formed. PPL at a predetermined
loading (mg cm–2) and different enhancer concentrations (%, m/m) was dissolved and
added to the gel. The viscous gel was left to stand until all air bubbles had disappeared.
The final solution was spread on a clean dry glass plate in a dust-free atmosphere and
dried at 50 °C for 24 h or at 37 °C for 48 h. The dry film obtained was peeled off, wrap-
ped in aluminium foil and stored in a well closed container at room temperature until
evaluation (7).
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Film characterization
Film thickness. – The thickness of films was measured at three different spots using a
micrometer (Mitutoyo Co., Japan) and mean values were calculated (Table I).
Determination of drug in the film. – A known mass of chitosan (1 g) film was dissolved
in acetic acid (2 %, m/V) up to 100 mL. Sample was filtered through membrane filter
0.45 mm. The concentration of PPL was measured at 290 nm by Cintra 5, UV spectropho-
tometer (GBC Scientific equipment, Australia). Measurements were taken against a blank
solution, which was prepared by repeating the former procedure on blank film (chitosan
film without drug).
Moisture uptake. – After keeping them (4 cm2) in desiccator with silica gel for 24
hours, the films were weighed. The films were then transferred to another desiccator con-
taining saturated NaCl solution (relative humidity 75 %) at 25 °C. After equilibrium was
achieved, the films were taken out and weighed. Moisture uptake capacity (MUC) was
calculated (8) (Table I).
In vitro bioadhesive strength measurement. – The bioadhesive strength of PPL films
was evaluated by employing a method described by Peh and Wong (7) using a texture
analyzer (TA.XT2, Stable Micro System, UK) and adjusted automatically by the same
computer software.
In vitro release study
The release of PPL was tested with a paddle type USP dissolution apparatus (Cop-
ley Scientific, UK) at 37 °C. The film was cut into a circle with an area of 3.14 cm2 and
sandwiched between double-sided sieves (as a weight). The film with the weight was
placed in a glass vessel filled with 500 mL of phosphate buffer (pH 7.4). The rotating
speed of the paddle was 50 rpm. The sample solutions (5 mL) were removed through a
syringe filter at predetermined time intervals. The withdrawn volume was replaced by
the same volume of phosphate buffer to maintain its constant volume and sink condi-
tions (9). The concentration of PPL was determined at 290 nm.
In vitro skin permeation
Preparation of skin membranes. – The study was approved by the Research Ethics
Committee of the College of Pharmacy, University of Baghdad, Iraq.
Male Wistar rats weighing approximately 150–200 g were sacrificed by ether inhala-
tion. The abdominal skin was lightly shaved with an electrical clipper, defatted by wip-
ing it with a cotton tip soaked in diethyl ether and kept in phosphate buffer pH 7.4 for 1 h.
The skin was either used immediately or frozen (–20 °C) until ready for use.
PPL permeation study. – Rat skin obtained previously was mounted in Franz diffu-
sion cells (Transdermal tester HDT 10, Copley Scientific, UK). The permeation area of
the cell was 3.14 cm2. The donor compartment was left open and wrapped with cello-
phane to prevent film contamination from the atmosphere; the receptor chamber was
filled with 17.7 mL of phosphate buffer pH 7.4, magnetically stirred at 600 rpm and ther-
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mostated at 37 °C. At predetermined periods of time, samples were taken from the re-
ceptor solution and analyzed for PPL content by HPLC.
The HPLC system consisted of a model LC-6A HPLC pump (Shimadzu, Japan) and
a UV detector (SPD-6A, Shimadzu) set at 289 nm. Analytical column was Inertsil ODS-3
(C18, 250 ´ 4.6 mm, GL Sciences, Japan). The mobile phase was CH3CN (20 mmol L–1) :
NH4Cl (0.05 %) phosphoric acid (1:1:1, V/V/V). The flow rate was set at 1 mL min–1 (8).
Each point on the standard curve was mean ± SD of three readings. RSD for standard
curves ranged from 0.1 to 18.7 %, and R2 was higher than 0.998.
Data of the skin permeation study was analyzed using two kinetic models, viz. the
first-order rate kinetics where the rate of drug permeation is concentration-dependent
and Higuchi model (10) which describes the release of drugs from an insoluble matrix
where the cumulative amount of the permeated drug per unit area is proportional to the












where c is the initial drug concentration in the donor compartment, Q is the cumulative
amount of the drug released at time, t and D is the diffusion coefficient.
Primary skin irritation
Three preparations were evaluated for their skin irritation, namely, blank film (chi-
tosan, 2 %, m/m), control film (PPL, 2 mg cm–2, chitosan, 2 %, m/m) and the candidate
film (PPL, 2 mg cm–2, chitosan, 2 %, m/m cineole, 10 %, m/m) in comparison with hista-
mine (a substance of known irritancy for the purpose of calibration). The test was per-
formed according to the reported method (11).
Statistical analysis
Results are expressed as the mean ± SD of at least three experiments. Analysis of




Estimation of the drug concentration at different points of chitosan films indicated
uniform distribution of PPL throughout the film of 96.1–100.7 % (Table I and II). Chi-
tosan concentration significantly (p < 0.05) increased the film thickness and decreased
the MUC. However, PPL loading tended to thicken the film and increased the moisture
uptake significantly (p < 0.05), except for 3 mg cm–2, PPL loading for which moisture up-
take were capacity changed slightly (Table I).
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Enhancers showed significant increase (p < 0.05) in MUC compared to the control
film (Table II). Cineol 10 %, m/m, showed the highest increment in film MUC. The rea-
son for this increment still needs to be investigated. However, propylene glycol can ab-
sorb moisture from the environment because of its humectant ability.
In vitro bioadhesion strength
Table III presents the data of adhesiveness and work of adhesion 12 obtained from
the texture analyzer for different chitosan films: blank film (chitosan 2 %, m/m), control
film (PPL 2 mg cm–2, chitosan 2 %, m/m) and the candidate film (PPL 2 mg cm–2, chito-
san 2 %, m/m, cineole 10 %, m/m). There were no significant differences in either adhe-
siveness or work of adhesion among the tested chitosan films. However, the blank film
showed the highest adhesiveness and work of adhesion. All the prepared films were ap-
plied on excised rat skin in vitro for 8 hours during permeation studies and it was found
that they firmly attached to the skin, indicating good adhesion properties for clinical use.
Release study
PPL release was found to be affected by chitosan concentration in the film. It de-
creased significantly (p < 0.05) as the concentration of chitosan, film forming agent, in-
creased in the film (Fig. 1a). The best drug release was obtained with 2 % (m/m) of chito-
san which was 51.2 % at the end of the run (after 8 hours). This effect is the same as that
obtained by Amnuaikit et al. (8), who studied the in vitro release profile of PPL from trans-
dermal films containing ethyl cellulose and polyvinyl pyrrolidine as film former.
The effect of PPL concentration on its release from chitosan film was studied by emplo-
ying three concentrations (1, 2 and 3 mg cm–2) in chitosan 2 % (m/m) as the film former.
It was found that increasing the loading of PPL in the film from 1 to 2 mg cm–2 resulted
in a significant increase (p < 0.05) of total drug release percentage from 33.4 % to 51.2 %,
respectively (Fig. 1b). Other researchers also reported that increasing the amount of PPL
dispersed in the film would increase membrane porosity, leading to a greater, release of
the drug (8).
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1 2 100.4 ± 2.5 0.30 ± 0.10 20.1 ± 1.3
2 1 97.7 ± 1.0 0.36 ± 0.05 13.4 ± 3.2
2 2 99.6 ± 3.3 0.50 ± 0.09 18.9 ± 5.4
2 3 100.5 ± 8.5 0.61 ± 0.08 19.6 ± 3.4
3 2 98.6 ± 5.5 0.60 ± 0.12 12.5 ± 4.8
4 2 98.9 ± 6.9 0.70 ± 0.06 8.80 ± 1.9
a Mean ± SD, n = 3.
However, the results could be explained on the basis that increasing PPL concentra-
tion enhanced the film MUC (Table I) and consequently increased the PPL solubility and
its release from the film.
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Table II. Physicochemical properties of PPL film formulations with different enhancers
Enhancers (% m/m) PPL content (%)a Thickness (mm)a MUC (%)a
Control film 2 mg cm–2 99.6 ± 3.3b 0.50 ± 0.09 18.9 ± 5.4
PG
5 98.8 ± 6.1 0.53 ± 0.05 19.7 ± 2.3
10 100.3 ± 2.9 0.60 ± 0.02 23.5 ± 1.1
15 96.6 ± 9.1 0.64 ± 0.03 23.1 ± 2.9
Menthol
5 97.9 ± 1.3 0.43 ± 0.09 20.1 ± 8.1
10 99.5 ± 2.3 0.53 ± 0.06 20.1 ± 2.5
Cineole
5 99.6 ± 4.5 0.50 ± 0.31 25.6 ± 2.6
10 98.7 ± 4.9 0.60 ± 0.07 26.8 ± 1.9
PG 10 % + cineole
5 100.7 ± 3.1 0.55 ± 0.02 21.1 ± 1.3
10 96.3 ± 1.2 0.53 ± 0.02 24.1 ± 1.6
PG 10 % + menthol
5 96.5 ± 6.5 0.60 ± 0.03 20.4 ± 6.3
10 99.1 ± 7.3 0.53 ± 0.08 24.0 ± 5.4
SLS
2.5 98.1 ± 3.2 0.60 ± 0.11 19.1 ± 4.8
5 100.1 ± 3.1 0.63 ± 0.12 19.9 ± 3.2
BZK
1 99.5 ± 6.4 0.51 ± 0.16 20.2 ± 4.7
2.5 96.9 ± 2.4 0.53 ± 0.06 23.1 ± 7.3
5 97.5 ± 3.1 0.53 ± 0.05 24.9 ± 1.4
Tween® 80
1 99.9 ± 1.6 0.51 ± 0.34 21.5 ± 2.6
2.5 100.0 ± 2.9 0.52 ± 0.13 23.1 ± 3.1
5 96.1 ± 1.1 0.52 ± 0.12 24.9 ± 2.8
Oleic acid
1 96.7 ± 1.2 0.50 ± 0.08 20.1 ± 1.8
5 98.8 ± 0.8 0.51 ± 0.09 25.1 ± 2.1
a Mean ± SD, n = 3.
b 2 mg PPL cm–2.
MUC moisture uptake capacity.
The increment of propylene glycol from 5 to 10 % (m/m) in the chitosan film signifi-
cantly enhanced (p < 0.05) the in vitro release of PPL. 65.0 % and 70.4 % of PPL was re-
leased during 8 h from the films containing 5 and 10 % PG, respectively, compared to
51.2 % released from the film without enthancer. However, a significant decrease in PPL
release (31.0 %) was obtained with propylene glycol 15 % (m/m). Larger amount of wa-
ter absorbed into the film by propylene glycol would contribute to the more rapid re-
lease of the drug from the film. On the other hand, the same humectants’ property at
higher concentrations may increase the viscosity of the film, resulting in slow drug re-
lease (13).
Moreover, addition of terpenes at a concentration of 5 % (m/m) tended to a signifi-
cant increase (p < 0.05) in PPL release profile while terpenes 10 % (m/m) showed even
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No enhancer
Tween 2.5 %, /m m
Tween 5 %, /m m
Tween 1 %, /m m
OA 1 %, /m m
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Fig. 1. Effect of: a) chitosan and PPL concentrations, b) terpenes (5 %, m/m), c) terpenes (10 %, m/m),
d) Tween 80 and oleic acid on PPL release profile from chitosan film preparations in phosphate buf-
fer (pH 7.4). Results are expressed as the mean with the bars showing SD values of three different
experiments.
higher increase, as shown in Figs. 1b and c. Hence, the increase in PPL release could be
correlated with the increase in MUC as enhancer concentration increased (Table II).
PPL in vitro release after 8 h using SLS 2.5 and 5 % (m/m) was 36.4 % and 42.0 %, re-
spectively, compared to chitosan film without enhancer (51.2 %). The decrease in PPL re-
lease might be attributed to the ability of the anionic surfactant, SLS, to form complexes
with the cationic drug via its negative charge. The presumed SLS-PPL complex may show
less solubility than the free PPL and consequently less release into the dissolution me-
dium (13). Another possibility for the retarding effect on PPL release is the increasing
film viscosity with increasing SLS concentration; however, further investigations are re-
quired to explain this effect.
Benzalkonium chloride (BZK) was used to check the effect of cationic surfactants on
PPL release. Concentrations of 2.5 and 5 % BZK showed an increase in the drug release
(56.4 and 60.6 %, respectively), after 8 hours compared to chitosan film without enhan-
cer (51.2 %). Wells and Parrott (14) suggested that this surfactant may lower the interfa-
cial tension between the product and the dissolution fluid; hence, it may contribute to
the increase in drug release from the prepared film.
In contrast, the concentration of the non-ionic surfactant, Tween 80, caused signifi-
cant (p < 0.05) PPL release from chitosan films (in the order: 5 > 2.5 > 1 %), as shown in
Fig. 1. This is probably due to the reduction in surface tension of the dissolution me-
dium, which allows more rapid release of PPL from the film. Moreover, the addition of
oleic acid (OA) of 1 and 5 % (m/m) led to a significant increase in the release of PPL (p <
0.05 and p < 0.001 respectively, Fig. 1d). The increase in release could be correlated to the
increase in MUC of the film matrix as a function of OA concentration.
In vitro skin permeation
Regression analysis of the obtained results showed that the Higuchi model gave the
highest value of R2 with a significant difference (p < 0.05) compared to other kinetic mo-
dels. Therefore, the Higuchi model was found to be a most suitable model to describe
the permeation kinetics of PPL from the film preparations examined in the present study.
The Higuchi rate constant was calculated and is summarized in Table IV.
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Blank film (2 %, m/m chitosan) 63.6 ± 5.6 12.9 ± 9.1
Control film (2 mg cm–2 PPL, 2 %, m/m chitosan) 62.5 ± 4.3 12.6 ± 3.2
Candidate film (PPL 2 mg cm–2, chitosan 2 % m/m,
cineole 10 %, m/m) 60.6 ± 2.9 12.5 ± 2.3
a Mean ± SD, n = 5.
Work of adhesion is defined as of the attraction between phases per unit area being in contact with each other
(g cm) (15).
Skin permeation of PPL significantly increased (p < 0.05) via increasing the loading
concentration of PPL in the prepared chitosan films (Table IV). This may be due to the
fact that the loading of PPL of 2 mg cm–2 tended to thicken the film and significantly en-
hance the capacity of moisture uptake.
Results showed that PG 5 % (m/m) significantly increased (p < 0.05) the permeation
rate constant of PPL (Table IV). However, when the concentration of PG increased to 10
and 15 % (m/m) in the film, a non-significant decrease in the permeation profile was ob-
served. For PG 5 % (m/m), the enhancement is possibly due to the increase in the so-
lublizing ability of the aqueous site in the stratum corneum considered to be the main
probable mechanism of increasing skin permeation for PG.
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Table IV. Higuchi’s permeation rate constant (k) ± SD and coefficient of determination (R2)
of the PPL-chitosan film preparations
Formula k (mg h–1/2)a R2
PPL (1 mg cm–2) 47.73 ± 1.88 0.892
PPL (2 mg cm–2, control) 97.56 ± 2.65 0.911
PG (5 %) 213.25 ± 3.80 0.979
PG (10 %) 107.75 ± 1.56 0.912
PG (15 %) 87.04 ± 5.98 0.839
Cineol (5 %) 226.61 ± 3.98 0.998
Cineole (5 % + PG 10 %) 230.15 ± 1.88 0.991
Menthol (5 %) 130.03 ± 1.27 0.985
Menthol (5 % + PG 10 %) 164.05 ± 8.76 0.989
Cineol (10 %) 379.92 ± 4.23 0.996
Cineole (10 % + PG 10 %) 296.02 ± 1.21 0.932
Menthol (10 %) 175.21 ± 6.61 0.837
Menthol (10 % + PG 10 %) 280.33 ± 1.32 0.902
SLS (1 %) 185.91 ± 1.72 0.994
SLS (2.5 %) 221.49 ± 4.32 0.972
SLS (5 %) 239.71 ± 3.51 0.990
Tween 80 (5 %) 273.19 ± 8.75 0.997
Tween 80 (2.5 %) 215.45 ± 7.97 0.967
Tween 80 (1 %) 182.91 ± 4.98 0.932
BZK (1 %) 114.75 ± 6.94 0.981
BZK (2.5 %) 134.28 ± 1.39 0.948
BZK (5 %) 246.21 ± 7.56 0.938
OA (1 %) 114.02 ± 1.93 0.897
OA (5 %) 310.33 ± 7.95 0.990
a Mean ± SD, n = 3.
Chitosan films containing terpenes 10 % generally gave significantly higher (p < 0.05)
permeation enhancement of PPL than 5 % concentrations, which is acceptable since the
effect of permeation enhancers often depends on their concentration.
Terpenes significantly increased penetration of PPL in the following order: cineole
and PG > menthol and PG > menthol 10 %. However, a highly significant effect (p <
0.001) was obtained with cineole 10 % (m/m) alone (Table IV). The possible mechanism
for cineole having the highest enhancing property among other terpenes, as suggested
by Barry and Williams (15), is that cineole would interact with the lipid component of
the stratum corneum more easily because its boiling point was lower than that of other
terpenes and the low boiling point is an indication of weak cohesiveness or self associa-
tion, which might explain why cineole showed the highest enhancing effect on skin per-
meation of PPL.
Although the increment in SLS concentrations did not significantly enhance in vitro
release of PPL, a raise in SLS concentration to 5 % (m/m) resulted in a significant in-
crease (p < 0.05) in PPL rat skin permeation (Table IV). It has been reported that an an-
ionic surfactant, like SLS, can penetrate and interact strongly with the skin, producing
considerable alterations in the barrier properties. For the non-ionic surfactant Tween 80,
the highest permeation was observed with the film containing a concentration of 5 %
(m/m) (p < 0.05) (Table IV). One of the possible mechanisms for the non-ionic surfactants
enhancement is that surfactant may penetrate into the intercellular region of the stratum
corneum, increasing fluidity and eventually solubilizing and extracting lipid components.
BZK produced the highest permeation at a concentration of 5 % (p < 0.05) (Table IV).
High concentration of BZK caused extensive damage to the skin and consequently in-
creased the PPL permeation profile.
On the other hand, OA 1 % seemes to have greater effect on permeation of PPL and
the permeation is significantly increased (p < 0.05) compared to OA 5 %. This may be
due to slowed down drug partitioning into the stratum corneum using a large amount
of OA. Previous studies have reported that OA-induced skin penetration enhancement
results from a mechanism involving both stratum corneum lipid fluidization and lipid
phase separation, with the latter likely to predominate.
CONCLUSIONS
To avoid extensive first-pass elimination and achieve the desirable transdermal pen-
etration rate of PPL, we have prepared polymeric film formulations for transdermal use
by employing chitosan as a film former, glycerin as a plasticizer and different types of
penetration enhancers. The film containing propranolol · HCl 2 mg cm–2, chitosan 2 %
and cineole 10 % successfully improved the skin penetration of PPL. Also, the candidate
film preparation was non irritant to the skin and was quite promising for safely achiev-
ing the desirable systemic absorption of PPL.
Acknowledgements. – The authors gratefully acknowledge financial support of the College of
Pharmacy, University of Baghdad, Baghdad, Iraq.
280
B. K. A. Rasool et al.: Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride, Acta Pharm.
61 (2011) 271–282.
REFERENCES
1. T. Kimura and K. Higaki, Gastrointestinal transit and drug absorption, Biol. Pharm. Bull. 25 (2002)
149–164; DOI: 10.1248/bpb.25.149.
2. K. Higaki, C. Amnuaikit and T. Kimura, Strategies for overcoming the stratum corneum: chemi-
cal and physical approaches, Am. J. Drug Deliv. 1 (2003) 187–214.
3. T. Sawamoto, S. Haruta, Y. Kurosaki, K. Higaki and T. Kimura, Prediction of plasma concentra-
tion profile of orally administered drugs based on gastrointestinal transit kinetics and absor-
bability in rats, J. Pharm. Pharmacol. 49 (1997) 450–457.
4. J. K. Kou, Transport in Polymer Systems, in Transport Processes in Pharmaceutical Systems (Ed. G. L.
Amidon), Marcel Dekker, New York 2000, pp. 445–471; DOI: 10.1201/9780203909478.ch12.
5. H. Schaefer and T. E. Redelmeier, Structure and Dynamics of the Skin Barrier, in Skin Barrier: Prin-
ciples of Percutaneous Absorption, Karger, Basel 1996, pp. 1–42.
6. M. Kitahara, F. Ishiguro, K. Takayama, K. Isowa and T. Nagai, Evaluation of skin damage of cy-
clic monoterpenes, percutaneous absorption enhancers by using cultured human skin cells, Biol.
Pharm. Bull. 16 (1993) 912–916.
7. K. K. Peh and C. F. Wong, Polymeric film as vehicle for buccal delivery: Swelling, mechanical
and bioadhesive properties, J. Pharm. Pharm. Sci. 2 (1999) 53–61.
8. C. Amnuaikit, I. Ikeuchi, K. Ogawara, K. Higaki, Kazutaka and T. Kimura, Skin permeation of
propranolol HCl from polymeric film containing terpene enhancers for transdermal use, Int. J.
Pharm. 289 (2005) 167–178; DOI: 10.1016/j.ijpharm.2004.11.007.
9. United States Pharmacopoeia 24/National Formulary 19, USP Convention, Rockville 2000, p. 2235.
10. T. Higuchi, Mechanism of sustained action medication. Theoretical analysis of rate of release of
solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145–1149; DOI: 10.1002/jps.
2600521210.
11. Standard Practice for Testing Biomaterials in Rabbits for Primary Skin Irritation, A.S.T.M. Designa-
tion F 719–81, American Society for Testing and Materials, Philadelphia 1998, pp. 178–179.
12. S. A. Yehia, O. N. El-Gazayerly and E. B. Basalious, Fluconazole mucoadhesive buccal films: in
vitro/in vivo performance, Current Drug Deliv. 6 (2009) 17–27; DOI: 10.2174/156720109787048195.
13. G. Yang, N. Jain and S. H. Yalkowsky, Combined effect of SLS and (SBE) 7M-b-CD on the so-
lubilization, Int. J. Pharm. 269 (2004) 141–148; DOI: 10.1016/j.ijpharm.2003.09.001.
14. M. L. Wells and E. L. Parrott, Effect of surfactants on release of a highly water-soluble medicinal
compound from an inert, heterogeneous matrix, J. Pharm. Sci. 81 (1992) 453–457; DOI: 10.1002/
jps.2600810513.
15. B. W. Barry and A. C. Williams, Human skin penetration enhancement: the synergy of propyl-
ene glycol with terpenes, Proc. Int. Symp. Control. Rel. Bioact. Mater. 16 (1989) 33–34.
281
B. K. A. Rasool et al.: Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride, Acta Pharm.
61 (2011) 271–282.
S A @ E T A K
Dizajniranje i vrednovanje bioadhezijskog filma za transdermalnu
isporuku propranolol hidroklorida
BAZIGHA K. ABDUL RASOOL, UDAY S. AZIZ, OMAR SARHEED i ALAA A. ABDUL RASOOL
Cilj rada bio je razvoj pogodnog transdermalnog sustava na bazi kitozana za ispo-
ruku propranolol hidroklorida (PPL). Svim pripravcima ispitana je jednoli~nost udjela
lijeka, debljina, sposobnost vla`enja i bioadhezivnost na ko`u. Ispitivan je i utjecaj kitoza-
na, koncentracije PPL-a i sredstva za pove}anje permeacije na osloba|anje i permeacijski
profil, te potencijalni iritacijski u~inak na ko`u. Iz kitozanskog filma (PPL 2 mg cm 2,
2 %, m/m, kitozana i 10 %, m/m, cineola), koji nije djelovao iritabilno, postignuto je 88,2 %
osloba|anja nakon 8 sati u fosfatnom puferu. S ovim pripravkom postignuta je i vrlo
zna~ajna (p < 0,001) permeacija PPL kroz ko`u {takora, oko osam puta ve}a u usporedbi
s filmom bez sredstva za pove}anje permeacije. Pripravak bi se mogao upotrijebiti za
transdermalnu isporuku PPL.
Klju~ne rije~i: transdermalna isporuka, propranolol hidroklorid, kitozanski film, sredstvo za pove-
}anje permeacije
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